THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Screening for prostate cancer using a blood test likely reduces the risk of dying from prostate cancer and may also reduce the risk of dying from any cause. Screening likely makes little to no ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

BARCELONA, Spain — Simple, temporary lifestyle changes may be able to spare men with mildly increased prostate-specific antigen (PSA) levels from having to endure a prostate biopsy, results of a ...

A Prostate-Specific Antigen (PSA) test is a procedure formed on men to detect prostate cancer. It is considered an effective means of cancer screening and can be used to monitor the effectiveness of ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

Prostate cancer overdiagnosis occurs when a person is diagnosed with prostate cancer through PSA testing – even though that cancer would not otherwise have been diagnosed within ...